Astellas Pharma Inc. - Diluted Average Shares

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in Billions.

The item "Diluted-Average-Shares" stands at 7.17 Billion for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

Astellas Pharma Inc.'s second quarter result of 1.80 Billion for the item "Diluted Average Shares" represents an increase of 0.13 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 1.80 Billion for the item "Diluted Average Shares" represents a decrease of -0.19 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 7.17 Billion for the item "Diluted Average Shares" represents a decrease of -0.05 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.7142 percent compared to the value the year prior.
The 1 year change in percent is -0.7142.
The 3 year change in percent is -2.33.
The 5 year change in percent is -3.95.
The 10 year change in percent is -18.28.

The Serie's long term average value is 8.08 Billion. It's latest available value, on 09/30/2025, is 11.20 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 12/31/2012, to it's latest available value, on 09/30/2025, is -22.34%.